Michael Gottlieb's most recent trade in POINT Biopharma Global Inc was a trade of 48,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 6, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc | Michael Gottlieb | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 48,000 | 48,000 | - | - | Stock Option (Right to Buy) |